AdvaMed, The Medtech Association®, is the world’s largest trade association representing medtech companies, ranging from multinational corporations to the smallest businesses and startups. The health care system relies on FDA…
AdvaMed, The Medtech Association®, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Robert F. Kennedy, Jr. to serve as Secretary of…
On the Medtech POV podcast, AdvaMed® President and CEO Scott Whitaker sat down with recently retired U.S. Rep. Brad Wenstrup of Ohio, discussing lessons learned from the COVID-19 pandemic, illogical budgetary scoring…
AdvaMed, The Medtech Association®, today released the following statement from President and CEO Scott Whitaker following the imposition of tariffs on products from Canada, Mexico, and China:
Today, AdvaMed, The Medtech Association®, released its “Patients First Agenda,” a series of state-level policies aimed at improving lives and patient outcomes through increasing access to medical technology, accurate diagnostic…
On the Medtech POV podcast , AdvaMed® President and CEO Scott Whitaker sat down with Jacob “Jake” Leach, Executive Vice President and Chief Operating Officer at Dexcom, to discuss the…
On the Medtech POV podcast, AdvaMed® President and CEO Scott Whitaker sat down with Martina Navratilova and Chris Evert, professional tennis legends who met as teen-age competitors and whose friendship…
AdvaMed, The Medtech Association®, commended the House of Representatives’ bipartisan Task Force on Artificial Intelligence for urging the Centers for Medicare & Medicaid Services (CMS) to develop a formalized payment…
AdvaMed, The Medtech Association®, asked the United States Court of Appeals to support a fair and balanced approach to patent damages.
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on President-elect Trump’s announcement that he intends to nominate Dr. Martin Makary to Lead FDA: